CRBP Crosses Above Average Analyst Target
January 22, 2021 at 07:53 AM EST
In recent trading, shares of Corbus Pharmaceuticals Holdings Inc (CRBP) have crossed above the average analyst 12-month target price of $1.84, changing hands for $2.36/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..